• Seres Therapeutics, Inc. Amends and Restates 2025 Incentive Award Plan in SEC 8-K Filing Minichart Thu, 09 Jul 2026 01:12:00 GMT
• Seres Therapeutics (NASDAQ: MCRB) investors back 900,000-share 2025 incentive plan increase Stock Titan Wed, 08 Jul 2026 20:05:55 GMT
• Why Is Seres Therapeutics Stock Falling Today? - Seres Therapeutics (NASDAQ:MCRB) Benzinga Wed, 08 Jul 2026 17:07:59 GMT
• Seres Therapeutics, Inc. (MCRB) Discusses Promising SER-155 Clinical Trial Results for Immune Checkpoint Inhibitor Related Andropi... Seeking Alpha Wed, 08 Jul 2026 17:00:36 GMT
• Seres’ SER-155 takes on immune checkpoint inhibitor-related enterocolitis BioWorld News Wed, 08 Jul 2026 16:00:00 GMT
• MCRB: All proposals, including director elections and incentive plan amendment, were approved TradingView Wed, 08 Jul 2026 13:26:47 GMT
• Seres reports trial results for experimental colitis treatment Investing.com Wed, 08 Jul 2026 12:51:39 GMT
• Seres Therapeutics' Phase 1 Trial of SER-155 Meets Primary Endpoint; Shares Rise Pre-Bell Moomoo Wed, 08 Jul 2026 12:43:25 GMT
• Seres Therapeutics (NASDAQ: MCRB) highlights promising SER-155 data and limited cash runway Stock Titan Wed, 08 Jul 2026 12:00:43 GMT
• Seres Therapeutics Announces Early Clinical Data Showing GlobeNewswire Wed, 08 Jul 2026 11:00:00 GMT
• Seres drug helped 80% of patients in cancer-therapy gut inflammation trial Stock Titan Wed, 08 Jul 2026 11:00:00 GMT
• Seres Therapeutics outlines its microbiome drug strategy as MCRB works to regain traction Ad-hoc-news.de Tue, 07 Jul 2026 13:46:33 GMT
• Price to book forward of Seres Therapeutics, Inc. – NASDAQ:MCRB TradingView Mon, 06 Jul 2026 13:43:12 GMT
• Seres Therapeutics updates its microbiome drug focus as investors weigh long-term prospects Ad-hoc-news.de Fri, 03 Jul 2026 17:44:13 GMT
• Seres Therapeutics (NASDAQ: MCRB) director receives 7,508-share stock option grant Stock Titan Thu, 02 Jul 2026 22:13:18 GMT
• Form 4 Seres Therapeutics Inc For: 2 July By Investing.com Investing.com Canada Thu, 02 Jul 2026 22:11:48 GMT
• Seres Therapeutics (NASDAQ: MCRB) director awarded 7,508 stock options at $7.94 Stock Titan Thu, 02 Jul 2026 22:10:24 GMT
• Seres Therapeutics (MCRB) director awarded 7,508 stock options vesting by 2027 Stock Titan Thu, 02 Jul 2026 22:06:30 GMT
• Clostridium Difficile Infections Market Forecast Signals Robust Industry Growth Through 2034 – DelveInsight | Seres Therapeutics, ... Barchart.com Tue, 30 Jun 2026 07:26:15 GMT
• price to sales forward of seres therapeutics, inc. – nasdaq:mcrb TradingView Sat, 27 Jun 2026 08:37:08 GMT
• seres to present ser-155 data for checkpoint inhibitor enterocolitis The Clinical Trial Vanguard Fri, 26 Jun 2026 06:53:06 GMT
• enterprise value to ebit forward of seres therapeutics, inc. – nasdaq:mcrb TradingView Fri, 26 Jun 2026 06:36:44 GMT
• price to earnings forward of seres therapeutics, inc. – nasdaq:mcrb TradingView Fri, 26 Jun 2026 05:53:34 GMT
• enterprise value to revenue forward of seres therapeutics, inc. – nasdaq:mcrb TradingView Fri, 26 Jun 2026 05:46:33 GMT
• Seres Therapeutics to Host Webcast on July 8, 2026, to GlobeNewswire Thu, 25 Jun 2026 07:00:00 GMT
• a new hope for cancer patients? seres to reveal key immunotherapy trial data BriefGlance Wed, 24 Jun 2026 23:12:40 GMT
• this insulet analyst begins coverage on a bullish note; here are top 5 initiations for tuesday Sahm Wed, 24 Jun 2026 07:28:03 GMT
• hc wainwright initiates seres therapeutics at buy with $12 price target Moomoo Tue, 23 Jun 2026 10:13:15 GMT
• H.C. Wainwright initiates Seres Therapeutics stock coverage with buy rating Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• H.C. Wainwright Initiates Seres Therapeutics(MCRB.US) With Buy Rating, Announces Target Price $12 Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• MCRB Initiates Coverage by HC Wainwright & Co. -- Rating Set to Buy GuruFocus Tue, 23 Jun 2026 07:00:00 GMT
• this insulet analyst begins coverage on a bullish note; here are top 5 initiations for tuesday Benzinga Tue, 23 Jun 2026 07:00:00 GMT
• Seres Therapeutics (MCRB) Q1 2026 Earnings: Wider-than-Expected Loss as Pipeline Development Continues dars.gov.et Mon, 22 Jun 2026 07:00:00 GMT
• Seres Therapeutics Inc (MCRB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 09:58:17 GMT
• seres therapeutics inc (mcrb) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 09:56:19 GMT
• seres therapeutics inc (mcrb) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 09:51:21 GMT
• seres therapeutics inc (mcrb) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 12:21:31 GMT
• seres therapeutics inc (mcrb) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 12:19:04 GMT
• seres therapeutics inc (mcrb) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 12:14:04 GMT
• seres therapeutics inc (mcrb) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 10:49:25 GMT
• seres therapeutics inc (mcrb) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 10:43:28 GMT
• seres therapeutics inc (mcrb) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Microbiome Therapeutics Market Size, Share | Forecast [2034] Fortune Business Insights Mon, 15 Jun 2026 07:00:00 GMT
• MCRB Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Phase - Analyst Earnings Estimate dars.gov.et Sun, 14 Jun 2026 07:00:00 GMT
• mcrb q1 2026 earnings: eps miss as seres therapeutics reports wider-than-expected loss - dividend cut risk dars.gov.et Sun, 14 Jun 2026 07:00:00 GMT
• We're A Little Worried About Seres Therapeutics' (NASDAQ:MCRB) Cash Burn Rate Yahoo Finance Sat, 13 Jun 2026 07:00:00 GMT
• Here's Why We're A Bit Worried About Seres Therapeutics' (NASDAQ:MCRB) Cash Burn Situation simplywall.st Sat, 13 Jun 2026 07:00:00 GMT
• seres therapeutics (mcrb) slips 2.62% as shares test key support at $6.00 - volume spike alerts dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT
• Seres Therapeutics stock (US81750R1023): Updates on microbiome pipeline and financing Ad-hoc-news.de Wed, 10 Jun 2026 07:00:00 GMT
• cambridge biotech surrenders half its lab space amid cash crunch The Business Journals Wed, 10 Jun 2026 01:00:00 GMT
• Cambridge biotech surrenders half its lab space amid cash crunch The Business Journals Tue, 09 Jun 2026 07:00:00 GMT
• mcrb stock declines as seres therapeutics pauses ser-155 phase 2 study and shrinks headcount by 30% Stocktwits Mon, 08 Jun 2026 09:56:07 GMT
• seres therapeutics: $25 million deal and lease restructuring extend cash runway into q1 2027 Pulse 2.0 Mon, 08 Jun 2026 02:02:34 GMT
• Seres Therapeutics: $25 Million Deal And Lease Restructuring Extend Cash Runway Into Q1 2027 Pulse 2.0 Sun, 07 Jun 2026 07:00:00 GMT
• seres strengthens balance sheet with $25 million nestlé deal The Pharma Letter Sat, 06 Jun 2026 13:58:48 GMT
• mcrb stock declines as seres therapeutics pauses ser-155 phase 2 study and shrinks headcount by 30% Stocktwits Fri, 05 Jun 2026 19:23:02 GMT
• seres therapeutics (mcrb) secures cash runway extension through key transactions GuruFocus Fri, 05 Jun 2026 17:32:57 GMT
• seres therapeutics secures $25m nestlé deal, extends cash runway grafa.com Fri, 05 Jun 2026 15:21:00 GMT
• Seres Therapeutics Strengthens Balance Sheet Through Nestlé Agreement and Lease Restructuring citybiz Fri, 05 Jun 2026 12:41:21 GMT
• Seres Therapeutics Extends Cash Runway to 2027 Through Financial Restructuring and Lease Adjustments geneonline.com Fri, 05 Jun 2026 11:22:51 GMT
• Seres Therapeutics Announces Two Transactions to Strengthen GlobeNewswire Fri, 05 Jun 2026 07:00:00 GMT
• Seres Therapeutics secures $25M from Nestlé Health Science Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• Fulcrum lays off majority of staff; Seres extends runway into 2027 Endpoints News Fri, 05 Jun 2026 07:00:00 GMT
• drugmaker seres gets $25m from nestlé, cuts boston-area lab lease costs Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• seres therapeutics secures $25 million from nestlé health science and reduces facility costs to enhance financial position Quiver Quantitative Fri, 05 Jun 2026 07:00:00 GMT
• seres therapeutics secures $25m from nestlé, restructures lease to extend cash runway into 2027 Minichart Fri, 05 Jun 2026 07:00:00 GMT
• seres therapeutics (nasdaq: mcrb) extends cash runway into 2027 Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• seres therapeutics, inc. files 8-k current report with sec detailing corporate information (may 30, 2026) Minichart Tue, 02 Jun 2026 07:00:00 GMT
• microbiome therapeutics market size, share | forecast [2034] Fortune Business Insights Mon, 01 Jun 2026 07:00:00 GMT
• [8-k] seres therapeutics, inc. reports material event | mcrb 8-k filing Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• mcrb sec filings - seres therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Thu, 21 May 2026 21:01:16 GMT
• mcrb: ai-driven microbiome therapeutics pipeline advances toward key clinical and commercial milestones TradingView Tue, 19 May 2026 07:00:00 GMT
• seres therapeutics stock (us81750r1023): what’s next after microbiome setback and restructuring? AD HOC NEWS Tue, 19 May 2026 07:00:00 GMT
• officer at seres therapeutics (nasdaq: mcrb) sells 79 shares under 10b5-1 tax plan Stock Titan Tue, 19 May 2026 07:00:00 GMT
• [form 4] seres therapeutics, inc. insider trading activity Stock Titan Tue, 19 May 2026 07:00:00 GMT
• teresa l. young sells shares; mcrb (nasdaq: mcrb) files form 144 notice Stock Titan Tue, 19 May 2026 07:00:00 GMT
• seres therapeutics (mcrb) officer sells shares after rsu vesting under 10b5-1 plan Stock Titan Tue, 19 May 2026 07:00:00 GMT
• microbiome therapeutics market size, share | forecast [2034] Fortune Business Insights Mon, 18 May 2026 07:00:00 GMT
• seres therapeutics stock (us81750r1023): q1 2026 figures keep microbiome pioneer in focus AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• seres therapeutics stock (us81750r1023): microbiome specialist updates investors after q1 2026 AD HOC NEWS Sat, 16 May 2026 07:00:00 GMT
• layoff tracker: takeda cuts 4,500, novartis lays off biomedical research staff BioSpace Fri, 15 May 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: novartis trims research team; takeda takes away 4.5k roles Fierce Biotech Fri, 15 May 2026 07:00:00 GMT
• seres therapeutics stock (us81750r1023): q1 2026 results and private placement AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: takeda takes away 4.5k roles; valneva reduces workforce Fierce Biotech Thu, 14 May 2026 07:00:00 GMT
• Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference Yahoo Finance Tue, 12 May 2026 07:00:00 GMT
• layoff tracker: gilead laying off vast majority of arcellx employees BioSpace Fri, 08 May 2026 07:00:00 GMT
• seres therapeutics stock price forecast. should you buy mcrb? StockInvest.us Fri, 08 May 2026 07:00:00 GMT
• ccorf maintains seres therapeutics(mcrb.us) with buy rating, maintains target price $22 Moomoo Wed, 06 May 2026 07:00:00 GMT
• seres therapeutics announces three presentations at 2026 escmid congress TipRanks Tue, 05 May 2026 23:18:41 GMT
• Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire Tue, 05 May 2026 07:00:00 GMT
• seres therapeutics reports q1 2026 loss, advances live biotherapeutics with key clinical data pending Pluang Tue, 05 May 2026 07:00:00 GMT
• seres therapeutics (nasdaq: mcrb) q1 2026 results and cash runway Stock Titan Tue, 05 May 2026 07:00:00 GMT
• seres therapeutics 1q 2026: revenue $358k, eps $(2.08) — 10-q summary TradingView Tue, 05 May 2026 07:00:00 GMT
• seres therapeutics (nasdaq: mcrb) q1 2026 loss and going-concern risk Stock Titan Tue, 05 May 2026 07:00:00 GMT
• Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated... Yahoo Finance Mon, 04 May 2026 07:00:00 GMT
• experimental ibd microbiome therapy earns ddw poster honor Stock Titan Mon, 04 May 2026 07:00:00 GMT
• seres therapeutics unveils promising preclinica... | pluang – crypto, stocks, gold & funds Pluang Mon, 04 May 2026 07:00:00 GMT
• seres presents preclinical data on ibd drug candidate ser-603 by investing.com Investing.com Canada Mon, 04 May 2026 07:00:00 GMT
• seres therapeutics inc expected to post a loss of $1.88 a share - earnings preview TradingView Fri, 01 May 2026 12:40:07 GMT
• mcrb stock declines as seres therapeutics pauses ser-155 phase 2 study and shrinks headcount by 30% MSN Thu, 30 Apr 2026 08:00:29 GMT
• fierce biotech layoff tracker 2026: autolus decreases headcount by 13%; replimune reduces staff Fierce Biotech Thu, 30 Apr 2026 07:00:00 GMT
• layoff tracker: passage axes 75% of staff, explores strategic alternatives BioSpace Thu, 30 Apr 2026 07:00:00 GMT
• layoff tracker: mucinex maker hits new jersey with more layoffs BioSpace Thu, 30 Apr 2026 07:00:00 GMT
• nestlé joins the microbiome therapeutics innovation group (mtig); krys araujo‑torres, md, mpp to represent company Yahoo Finance Wed, 29 Apr 2026 07:00:00 GMT
• seres therapeutics (mcrb) projected to post quarterly earnings on wednesday MarketBeat Wed, 29 Apr 2026 07:00:00 GMT
• mcrb stock declines as seres therapeutics pauses ser-155 phase 2 study and shrinks headcount by 30% MSN Wed, 29 Apr 2026 06:42:54 GMT
• microbiome therapeutics market size, share | forecast [2034] Fortune Business Insights Mon, 27 Apr 2026 07:00:00 GMT
• microbiome therapeutics market is going to booming growth openPR.com Mon, 27 Apr 2026 07:00:00 GMT
• equity plan and director votes in seres therapeutics (nasdaq: mcrb) 2026 proxy Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• mcrb stock declines as seres therapeutics pauses ser-155 phase 2 study and shrinks headcount by 30% MSN Sun, 26 Apr 2026 01:42:57 GMT
• mcrb stock declines as seres therapeutics pauses ser-155 phase 2 study and shrinks headcount by 30% MSN Sat, 25 Apr 2026 17:56:16 GMT
• mcrb price today: seres therapeutics, inc. stock price, quote & chart | mexc MEXC Exchange Fri, 24 Apr 2026 07:00:00 GMT
• layoff tracker: tempero winding down following serious adverse event BioSpace Fri, 24 Apr 2026 07:00:00 GMT
• seres therapeutics stock price forecast. should you buy mcrb? StockInvest.us Fri, 24 Apr 2026 07:00:00 GMT
• seres therapeutics (nasdaq:mcrb) shares pass below 200 day moving average - here's what happened MarketBeat Wed, 22 Apr 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: replimune reduces staff; astellas shutters cell therapy site Fierce Biotech Tue, 21 Apr 2026 07:00:00 GMT
• seres therapeutics (mcrb) showcases research at escmid 2026 cong GuruFocus Mon, 20 Apr 2026 16:41:15 GMT
• Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 GlobeNewswire Mon, 20 Apr 2026 07:00:00 GMT
• seres therapeutics (mcrb) presents key data at escmid congress GuruFocus Mon, 20 Apr 2026 07:00:00 GMT
• seres spotlights microbiome data for transplant patients at escmid Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• seres therapeutics announces three presentations at 2026 escmid congress TipRanks Mon, 20 Apr 2026 07:00:00 GMT
• layoff tracker: bms layoffs hits lawrenceville hard, adding 200+ to cut count BioSpace Mon, 20 Apr 2026 07:00:00 GMT
• seres therapeutics stock (us81750r1023): is its microbiome platform strong enough to unlock biotech AD HOC NEWS Sat, 18 Apr 2026 19:43:24 GMT
• layoff tracker: astellas’ consolidation efforts to impact 50 universal cells employees BioSpace Fri, 17 Apr 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: astellas shutters cell therapy site; replimune reduces staff Fierce Biotech Tue, 14 Apr 2026 07:00:00 GMT
• microbiome therapeutics market size, share | forecast [2034] Fortune Business Insights Mon, 13 Apr 2026 07:00:00 GMT
Seres Therapeutics, Inc(NASDAQ:MCRB) 
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that ...
Website: http://www.serestherapeutics.com
Founded: 2010
Full Time Employees: 108
Sector: Healthcare
Industry: Biotechnology